Related Experiment Video
Updated: Jan 29, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.
Narendra Kumar Gonepudi1, Harry Baffour Awuah1, Wang Xu1
1Department of Cellular and Molecular Biology, School of Medicine, University of Texas at Tyler Health Science Center, Tyler, TX 75708, USA.
Peptide inhibitors targeting viral fusion proteins offer a promising antiviral strategy. Enhancements like stabilization and conjugation create potent, broad-spectrum agents against enveloped viruses.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Viral fusion proteins mediate viral entry into host cells, making them key targets for antiviral therapies.
- Class I fusion proteins, common in enveloped viruses like HIV-1 and SARS-CoV-2, possess conserved structural elements crucial for membrane fusion.
- Peptide inhibitors mimicking heptad repeat motifs are effective in blocking viral fusion.
Purpose of the Study:
- To review design strategies for peptide-based fusion inhibitors.
- To highlight optimization techniques for enhanced antiviral peptide efficacy.
- To provide insights for developing next-generation fusion inhibitors.
Main Methods:
- Summarizing design strategies for peptide inhibitors.
- Analyzing sequence and structural insights for optimization.
- Illustrating strategies with examples from various viral systems.
Main Results:
- Optimization techniques include α-helical stabilization, hydrocarbon stapling, lactam bridges, lipid conjugation, macrocyclization, and multivalency.
- These strategies yield potent and stable antiviral peptides.
- Developed peptides demonstrate broad-spectrum activity against major viral systems.
Conclusions:
- Rational design of peptide fusion inhibitors can lead to effective antiviral agents.
- Optimized peptides show promise for combating viral infections.
- Further development of these inhibitors could lead to next-generation antiviral therapies.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:06Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
Published on: March 9, 2019
Related Concept Videos
Viral Structure
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Tagging and Fusion Proteins
Size and Structure of Viral Genomes